- $13.35m
- $12.16m
- $22.10m
- 62
- 54
- 15
- 40
Annual cashflow statement for Psychemedics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.54 | -3.86 | -0.665 | -1.08 | -4.15 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.792 | 1.59 | -0.532 | 1.82 | 1.98 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.534 | -4.17 | -0.802 | 2.32 | -1.73 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 4.31 | -4.08 | 0.414 | 4.89 | -1.48 |
| Capital Expenditures | -1.68 | -0.991 | -0.182 | -0.187 | -0.157 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3.75 | 0.133 | -0.038 | -0.021 | -0.002 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.08 | -0.858 | -0.22 | -0.208 | -0.159 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3 | 0.501 | -1.03 | -1.92 | -1.15 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.21 | -4.45 | -0.841 | 2.76 | -2.79 |